Company profile TNXP

Tonix Pharmaceuticals Holding Corp
tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind applicati...on stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com. Show More
Quarter analysis & expected interestLast update: February 09 2024 12:03:39.

After 39 days of this quarter the interest is at 12.0. Based on that we can calculate that during remaining 52 days it will total up to 28.0.
Tonix Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-56.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
201920
18
-10.0% QoQ
8
-55.6% QoQ
15
87.5% QoQ
2020 128
540.0% YoY 753.3% QoQ
99
450.0% YoY -22.7% QoQ
342
4175.0% YoY 245.5% QoQ
134
793.3% YoY -60.8% QoQ
2021 482
276.6% YoY 259.7% QoQ
305
208.1% YoY -36.7% QoQ
161
-52.9% YoY -47.2% QoQ
122
-9.0% YoY -24.2% QoQ
2022 84
-82.6% YoY -31.1% QoQ
124
-59.3% YoY 47.6% QoQ
89
-44.7% YoY -28.2% QoQ
35
-71.3% YoY -60.7% QoQ
2023 64
-23.8% YoY 82.9% QoQ
47
-62.1% YoY -26.6% QoQ
37
-58.4% YoY -21.3% QoQ
32
-8.6% YoY -13.5% QoQ
2024 12
-81.2% YoY -62.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Tonix Pharmaceuticals search interestLast update: February 09 2024 12:03:38.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 12:03:40.

The average 5 years interest of Tonix Pharmaceuticals was 9.03 per week.
The last year interest of Tonix Pharmaceuticals compared to the last 5 years has changed by -67.22%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 102.74%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 12:03:46.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Tonix Pharmaceuticals Holding Corp expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
20190
0
45
inf% QoQ
49
8.9% QoQ
2020 197
inf% YoY 302.0% QoQ
31
inf% YoY -84.3% QoQ
245
444.4% YoY 690.3% QoQ
117
138.8% YoY -52.2% QoQ
2021 60
-69.5% YoY -48.7% QoQ
56
80.6% YoY -6.7% QoQ
164
-33.1% YoY 192.9% QoQ
52
-55.6% YoY -68.3% QoQ
2022 0
-100.0% YoY -100.0% QoQ
111
98.2% YoY inf% QoQ
179
9.1% YoY 61.3% QoQ
108
107.7% YoY -39.7% QoQ
2023 117
inf% YoY 8.3% QoQ
242
118.0% YoY 106.8% QoQ
112
-37.4% YoY -53.7% QoQ
124
14.8% YoY 10.7% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Tonix Pharmaceuticals Holding Corp search interestLast update: February 09 2024 12:03:45.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 12:03:47.

The average 5 years interest of Tonix Pharmaceuticals Holding Corp was 7.7 per week.
The last year interest of Tonix Pharmaceuticals Holding Corp compared to the last 5 years has changed by 33.9%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 312.4%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TNX-1500 to provide analysis

Correlation between past revenue and TNX-1500 search interest

There is not enough data for TNX-1500 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TNX-1500 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TNX-2900 to provide analysis

Correlation between past revenue and TNX-2900 search interest

There is not enough data for TNX-2900 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TNX-2900 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TNX-801 to provide analysis

Correlation between past revenue and TNX-801 search interest

There is not enough data for TNX-801 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TNX-801 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TNX-1840 to provide analysis

Correlation between past revenue and TNX-1840 search interest

There is not enough data for TNX-1840 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TNX-1840 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for TNX-1850 to provide analysis

Correlation between past revenue and TNX-1850 search interest

There is not enough data for TNX-1850 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for TNX-1850 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 12:03:54.

After 39 days of this quarter the interest is at 77.0. Based on that we can calculate that during remaining 52 days it will total up to 180.0.
TNX-102 SL expected interest is significantly higher compared to previous quarter (+300.0%) and same quarter last year (+116.9%).

YearQ1Q2Q3Q4
201977
39
-49.4% QoQ
147
276.9% QoQ
20
-86.4% QoQ
2020 100
29.9% YoY 400.0% QoQ
105
169.2% YoY 5.0% QoQ
157
6.8% YoY 49.5% QoQ
25
25.0% YoY -84.1% QoQ
2021 115
15.0% YoY 360.0% QoQ
122
16.2% YoY 6.1% QoQ
105
-33.1% YoY -13.9% QoQ
83
232.0% YoY -21.0% QoQ
2022 24
-79.1% YoY -71.1% QoQ
90
-26.2% YoY 275.0% QoQ
98
-6.7% YoY 8.9% QoQ
35
-57.8% YoY -64.3% QoQ
2023 83
245.8% YoY 137.1% QoQ
49
-45.6% YoY -41.0% QoQ
0
-100.0% YoY -100.0% QoQ
45
28.6% YoY inf% QoQ
2024 77
-7.2% YoY 71.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and TNX-102 SL search interestLast update: February 09 2024 12:03:53.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 12:03:56.

The average 5 years interest of TNX-102 SL was 6.11 per week.
The last year interest of TNX-102 SL compared to the last 5 years has changed by -38.95%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -31.43%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 12:04:00.

After 39 days of this quarter the interest is at 75.0. Based on that we can calculate that during remaining 52 days it will total up to 175.0.
TNX-1900 expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+41.1%).

YearQ1Q2Q3Q4
201924
109
354.2% QoQ
88
-19.3% QoQ
77
-12.5% QoQ
2020 59
145.8% YoY -23.4% QoQ
39
-64.2% YoY -33.9% QoQ
92
4.5% YoY 135.9% QoQ
83
7.8% YoY -9.8% QoQ
2021 147
149.2% YoY 77.1% QoQ
201
415.4% YoY 36.7% QoQ
118
28.3% YoY -41.3% QoQ
81
-2.4% YoY -31.4% QoQ
2022 80
-45.6% YoY -1.2% QoQ
119
-40.8% YoY 48.8% QoQ
97
-17.8% YoY -18.5% QoQ
125
54.3% YoY 28.9% QoQ
2023 124
55.0% YoY -0.8% QoQ
0
-100.0% YoY -100.0% QoQ
44
-54.6% YoY inf% QoQ
0
-100.0% YoY -100.0% QoQ
2024 75
-39.5% YoY inf% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and TNX-1900 search interestLast update: February 09 2024 12:04:00.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 12:04:01.

The average 5 years interest of TNX-1900 was 6.83 per week.
The last year interest of TNX-1900 compared to the last 5 years has changed by -42.9%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -38.78%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for TNXP
Earnings date: 2024-03-11 After close
Company name: Tonix Pharmaceuticals Holding Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

2026-05-12T20:30:00Z

GlobeNewswire
Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

2026-05-11T20:30:00Z

GlobeNewswire
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights

2026-05-06T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients

2026-05-04T17:52:57Z

Analyst Upgrades
TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22

2026-04-29T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University

2026-04-23T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026

2026-04-15T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development

2026-03-31T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026

2026-03-26T11:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain

2026-03-23T20:32:42Z

GlobeNewswire
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

2026-03-12T21:30:00Z

GlobeNewswire
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

2026-03-10T12:00:00Z

GlobeNewswire
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia

2026-03-09T20:30:00Z

GlobeNewswire
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

2026-03-05T21:15:00Z

GlobeNewswire
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development